K&L Gates Advises Ridgemont Equity Partners on Acquisition of Tech-Enabled Medical Products Distributor

6 October 2017
Charlotte - Global law firm K&L Gates LLP advised Ridgemont Equity Partners, a middle market private equity investor, on the acquisition of HemaSource Intermediate Holdings, LLC (“HemaSource” or the “Company”), the leading technology-enabled distributor of medical products to the plasma collection industry.

HemaSource, headquartered in Utah, distributes consumable products across 1,300 stock keeping units from two strategically located distribution centers. The Company utilizes a proprietary cloud-based inventory management and business intelligence software solution to help its customers gain supply chain efficiencies and decrease their plasma collection costs.

Ridgemont Equity Partners is a Charlotte-based middle market buyout and growth equity investor. Since 1993, the principals of Ridgemont have invested over $3.5 billion in 140 companies. The firm focuses on investments of $25 million to $100 million in industries in which it has deep expertise, including basic industries and services, energy, health care, and telecommunications/media/technology.

K&L Gates’ cross-practice, cross-office team was led by Rick Giovannelli and John Blair and also included James Fajkowski, Michael Hinckle, Christine Hoke, Mary Scott Kennedy, David Lindsay, Jared Mobley and Richard Nettles among others.
Please enable JavaScript, then refresh this page. JavaScript is required on this site.